品牌 | 其他品牌 | 貨號 | BFN607200603 |
---|---|---|---|
規格 | T25培養瓶x1 1.5ml凍存管x2 | 供貨周期 | 現貨 |
主要用途 | 僅供科研 | 應用領域 | 醫療衛生,生物產業 |
細胞名稱 | 人乳腺癌細胞MCF-7 | ||
貨物編碼 | BFN607200603 | ||
產品規格 | T25培養瓶x1 | 1.5ml凍存管x2 | |
細胞數量 | 1x10^6 | 1x10^6 | |
保存溫度 | 37℃ | -198℃ | |
運輸方式 | 常溫保溫運輸 | 干冰運輸 | |
安全等級 | 1 | ||
用途限制 | 僅供科研用途 1類 |
培養體系 | DMEM高糖培養基+20%FBS+1%三抗 | ||
培養溫度 | 37℃ | 二氧化碳濃度 | 5% |
簡介 | 人乳腺癌細胞MCF-7細胞是從一名69歲的白人女性乳腺癌患者的胸腔積液中分離建立的。該細胞保留了多個分化乳腺上皮的特性,包括:能通過胞質雌激素受體加工雌二醇并能形成隆突結構(domes);該細胞表達WNT7B癌基因;TNF-α可以抑制MCF-7細胞的生長;抗雌激素處理能調節細胞胰島素樣生長因子結合蛋白(IGFBP)的分泌。人乳腺癌細胞MCF-7細胞引種自ATCC HIB-22。 | ||
注釋 | Group: Space-flown cell line (cellonaut). Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: GrayJW Breast Cancer Cell Line Panel. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377). Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 31.2 hours (PubMed=22628656); 25.4 hours (NCI-DTP); ~50 hours, with a range of 30-72 hours (DSMZ); ~38 hours (PBCF); 56.47 hours Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Glycoproteome analysis by proteomics. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: Myristoylated proteins analysis by proteomics. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Anecdotal: This is the first hormone-responsive breast cancer cell line to have been established. Anecdotal: Helen Mallon (sister Catherine Frances), the patient from which this cell line is derived was a nun (Sister Catherine Frances) at the Immaculate Heart of Mary Convent in Monroe, Michigan. Anecdotal: Have been flown in space on Foton-12 to study cytoskeleton architecture in microgravity (PubMed=11292682; PubMed=15002416). Misspelling: MFC-7; Occasionally. | ||
STR信息 | Amelogenin:X;CSF1PO:10;D13S317:11;D16S539:11,12;D18S51:14;D19S433:13,14;D21S11:30;D2S1338:21,23;D3S1358:16;D5S818:11,12;D7S820:8,9;D8S1179:10,14;FGA:23,24,25;TH01:6;TPOX:9,12;vWA:14,15; | ||
參考文獻 | PubMed=28287265; DOI=10.1021/acs.jproteome.6b00470 Yen T.-Y., Bowen S., Yen R., Piryatinska A., Macher B.A., Timpe L.C. Glycoproteins in claudin-low breast cancer cell lines have a unique expression profile. J. Proteome Res. 16:1391-1400(2017)
PubMed=28601559; DOI=10.1016/j.cels.2017.05.009 Bekker-Jensen D.B., Kelstrup C.D., Batth T.S., Larsen S.C., Haldrup C., Bramsen J.B., Sorensen K.D., Hoyer S., Orntoft T.F., Andersen C.L., Nielsen M.L., Olsen J.V. An optimized shotgun strategy for the rapid generation of comprehensive human proteomes. Cell Syst. 4:587-599.e4(2017)
PubMed=28889351; DOI=10.1007/s10549-017-4496-x Saunus J.M., Smart C.E., Kutasovic J.R., Johnston R.L., Kalita-de Croft P., Miranda M., Rozali E.N., Vargas A.C., Reid L.E., Lorsy E., Cocciardi S., Seidens T., McCart Reed A.E., Dalley A.J., Wockner L.F., Johnson J., Sarkar D., Askarian-Amiri M.E., Simpson P.T., Khanna K.K., Chenevix-Trench G., Al-Ejeh F., Lakhani S.R. Multidimensional phenotyping of breast cancer cell lines to guide preclinical research. Breast Cancer Res. Treat. 167:289-301(2018)
PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747 Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A. An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines. Cancer Res. 79:1263-1273(2019)
PubMed=31068700; DOI=10.1038/s41586-019-1186-3 Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569:503-508(2019) |
驗收細胞注意事項
1、收到人乳腺癌細胞MCF-7細胞,請查看瓶子是否有破裂,培養基是否漏出,是否渾濁,如有請盡快聯系。
2、收到人乳腺癌細胞MCF-7細胞 ,如包裝完好,請在顯微鏡下觀察細胞。,由于運輸過程中的問題,細胞培養瓶中的貼壁細胞有可能從瓶壁中脫落下來,顯微鏡下觀察會出現細胞懸浮的情況,出現此狀態時,請不要打開細胞培養瓶,應立即將培養瓶置于細胞培養箱里靜止 3-5 小時左右,讓細胞先穩定下,再于顯微鏡下觀察,此時多數細胞會重新貼附于瓶壁。如細胞仍不能貼壁,請用臺盼藍染色法鑒定細胞活力,如臺盼藍染色證實細胞活力正常請按懸浮細胞的方法處理。
3、收到人乳腺癌細胞MCF-7細胞后,請鏡下觀察細胞,用恰當方式處理細胞。若懸浮的細胞較多,請離心收集細胞,接種到一個新的培養瓶中。棄掉原液,使用新鮮配制的培養基,使用進口胎牛血清。剛接到細胞,若細胞不多時 血清濃度可以加到 15%去培養。若細胞迏到 80%左右 ,血清濃度還是在 10%。
4、收到人乳腺癌細胞MCF-7細胞時如無異常情況 ,請在顯微鏡下觀察細胞密度,如為貼壁細胞,未超過80%匯合度時,將培養瓶中培養基吸出,留下 5-10ML 培養基繼續培養:超過 80%匯合度時,請按細胞培養條件傳代培養。如為懸浮細胞,吸出培養液,1000 轉/分鐘離心 3 分鐘,吸出上清,管底細胞用新鮮培養基懸浮細胞后移回培養瓶。
5、將培養瓶置于 37℃培養箱中培養,蓋子微微擰松。吸出的培養基可以保存在滅菌過的瓶子里,存放于 4℃冰箱,以備不時之需。
6、24 小時后,細胞形態已恢復并貼滿瓶壁,即可傳代。(貼壁細胞)將培養瓶里的培養基倒去,加 3-5ml(以能覆蓋細胞生長面為準)PBS 或 Hanks’液洗滌后棄去。加 0.5-1ml 0.25%含 EDTA 的胰酶消化,消化時間以具體細胞為準,一般 1-3 分鐘,不超過 5 分鐘。可以放入37℃培養箱消化。輕輕晃動瓶壁,見細胞脫落下來,加入 3-5ml 培養基終止消化。用移液管輕輕吹打瓶壁上的細胞,使之*脫落,然后將溶液吸入離心管內離心,1000rpm/5min。棄上清,視細胞數量決定分瓶數,一般一傳二,如細胞量多可一傳三,有些細胞不易傳得過稀,有些生長較快的細胞則可以多傳幾瓶,以具體細胞和經驗為準。(懸浮細胞)用移液管輕輕吹打瓶壁,直接將溶液吸入離心管離心即可。
7、貼壁細胞 ,懸浮細胞。嚴格無菌操作。換液時,換新的細胞培養瓶和換新鮮的培養液,37℃,5%CO2 培養。
特別提醒: 原瓶中培養基不宜繼續使用,請更換新鮮培養基培養。